While 2023 net revenue was 26% lower than that peak, as interest rates and economic uncertainty increased, the firm appears to have stabilized and looks poised for a return to high-single-digit ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...

Mike “Magicman” Byrne has been a part of the MMOBomb family for years and serves as the site’s current Editor-in-Chief. His ...

Evercore ISI notes that the fourth-generation iPhone SE is expected to be released sometime around March, with a launch announcement expected ...

New Mexico Educational Retirement Board lowered its stake in shares of PulteGroup, Inc. (NYSE:PHM – Free Report) by 2.9% during the fourth quarter, according to its most recent Form 13F filing with ...

Specialty MGA Optio Group has retained investment bank Evercore with a mandate to explore its debt options, as the business ...

Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's optimism is driven by upcoming catalysts that could mark a new chapter for the company.